Building Meaningful KOL Relationships: Understanding Expert Goals and Creating Long-Term Engagement

Effective KOL engagement starts with understanding the experts behind the science. Key Opinion Leaders (KOLs) bring their own clinical interests, research priorities, professional goals and perspectives to every interaction. For pharmaceutical and biotech clinical development and medical affairs teams, understanding those priorities is essential to building productive, long-term relationships.

The strongest KOL relationships are built through relevant scientific exchange, thoughtful engagement and opportunities that create value for both the expert and the organization. Here are several considerations for developing a meaningful KOL engagement strategy.

Start With the KOL's Clinical and Scientific Priorities

KOLs are first and foremost healthcare professionals and scientific experts. Their work may span patient care, clinical research, education, publications, professional societies and other areas of scientific leadership. Effective engagement begins with understanding the clinical and scientific priorities that matter to them.

That should be the foundation of KOL engagement. Rather than beginning with what the organization wants from an expert, clinical development and medical affairs teams should first understand where the KOL's expertise, interests and priorities intersect with the scientific questions the organization is trying to address.

Understand Their Interests and Goals

KOL interests can vary considerably. One expert may be particularly interested in clinical research, while another may focus on medical education, evidence generation, health economics, publications or improving care within a particular patient population.

Understanding those interests allows teams to create engagement opportunities that are relevant to the expert's experience and expertise. Depending on the individual, those opportunities might include:

Scientific advisory boards and roundtables

• Clinical research and investigator opportunities
• Medical education
• Publications and scientific communications
• Congress engagement
• Ongoing scientific exchange

The objective isn't simply to identify what a KOL might be willing to do. It's to understand where their expertise and interests can contribute meaningfully to the scientific and clinical questions your organization is addressing

Ask, Listen and Learn

Understanding a KOL's goals doesn't need to be complicated. Ask thoughtful questions, listen carefully and do your research before the interaction. Review their recent publications, clinical research, congress activity and areas of scientific interest so the conversation can begin from an informed perspective.

Questions might include:

• What clinical or scientific questions are you most interested in exploring?
• Where do you see the greatest unmet needs in this disease area?
• What research questions do you believe still need to be answered?
• Are there particular types of scientific collaboration or education that interest you?

The goal is not to manufacture a personal relationship. It is to build trust through relevant, respectful and consistent scientific engagement.

Align KOL Interests With Meaningful Opportunities

After you understand the KOL’s goals, it’s time to align their interests with the company or group’s goals. Differences will exist whether this is for a commercial or medical group. The same word applies to both: value.

Once you understand an expert's interests, look for appropriate opportunities where those interests intersect with your organization's scientific objectives. That might involve an advisory board, investigator meeting, research initiative, publication, congress engagement or ongoing scientific exchange.

Not every KOL should participate in every initiative. Thoughtful engagement means matching the right expert with the right opportunity at the right time.

Create Opportunities for Ongoing Engagement

In-person meetings remain valuable opportunities to deepen KOL relationships, particularly at advisory boards, investigator meetings and medical congresses. Virtual engagements and individual conversations can also play an important role between larger meetings.

The key is continuity. Rather than treating each interaction as a standalone event, consider how advisory boards, congress engagements, 1:1 discussions and other touchpoints can form part of a thoughtful, ongoing engagement plan.

Follow Up

Follow-up is an important part of KOL engagement. After a meeting, acknowledge the expert's contribution and, where appropriate, communicate how insights are being considered or what the next steps will be.At subsequent engagements, close the feedback loop. Refer back to previous discussions, provide relevant updates and demonstrate that the expert's time and perspectives were valued. This creates continuity and helps each interaction build on the last.

Focus on Long-Term Value

Strong KOL relationships develop over time. Consistent, relevant engagement allows organizations to better understand external perspectives while giving experts meaningful opportunities to contribute their scientific and clinical expertise.

A well-designed KOL engagement strategy should therefore extend beyond individual meetings. The goal is to create a thoughtful series of interactions that remain relevant to the expert, aligned with organizational needs and grounded in meaningful scientific exchange.

SBHC partners with pharmaceutical and biotech clinical development and medical affairs teams to design and execute KOL engagement strategies, from advisory boards and investigator meetings to congress engagements, 1:1 interactions and ongoing KOL initiatives.

Planning your next KOL engagement initiative? Let's talk.